MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 155 filers reported holding MEDICINES CO in Q3 2014. The put-call ratio across all filers is 9.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,295,000 | +51.7% | 132,981 | -10.7% | 0.03% | +36.8% |
| Q3 2019 | $7,444,000 | +39.2% | 148,881 | +1.5% | 0.02% | +35.7% |
| Q2 2019 | $5,349,000 | +30.5% | 146,681 | 0.0% | 0.01% | +40.0% |
| Q1 2019 | $4,100,000 | +46.1% | 146,681 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $2,807,000 | -36.0% | 146,681 | 0.0% | 0.01% | -20.0% |
| Q3 2018 | $4,387,000 | -18.5% | 146,681 | 0.0% | 0.01% | -23.1% |
| Q2 2018 | $5,383,000 | +11.4% | 146,681 | 0.0% | 0.01% | +8.3% |
| Q1 2018 | $4,832,000 | +20.2% | 146,681 | -0.2% | 0.01% | +20.0% |
| Q4 2017 | $4,019,000 | -26.2% | 147,007 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $5,445,000 | -3.7% | 147,007 | -1.2% | 0.01% | 0.0% |
| Q2 2017 | $5,656,000 | -22.3% | 148,807 | 0.0% | 0.01% | -26.3% |
| Q1 2017 | $7,277,000 | +44.1% | 148,807 | 0.0% | 0.02% | +46.2% |
| Q4 2016 | $5,051,000 | -10.1% | 148,807 | 0.0% | 0.01% | -13.3% |
| Q3 2016 | $5,616,000 | +12.2% | 148,807 | 0.0% | 0.02% | +15.4% |
| Q2 2016 | $5,004,000 | +6.0% | 148,807 | +0.1% | 0.01% | +8.3% |
| Q1 2016 | $4,721,000 | -14.9% | 148,607 | +0.1% | 0.01% | -20.0% |
| Q4 2015 | $5,545,000 | +40.6% | 148,507 | +42.9% | 0.02% | +36.4% |
| Q3 2015 | $3,944,000 | +32.9% | 103,907 | +0.2% | 0.01% | +37.5% |
| Q2 2015 | $2,968,000 | +20.5% | 103,749 | +18.0% | 0.01% | +33.3% |
| Q1 2015 | $2,464,000 | -47.5% | 87,936 | -48.1% | 0.01% | 0.0% |
| Q4 2014 | $4,690,000 | +160.0% | 169,472 | +109.6% | 0.01% | +20.0% |
| Q3 2014 | $1,804,000 | -23.1% | 80,836 | +0.1% | 0.01% | -16.7% |
| Q2 2014 | $2,346,000 | +2.2% | 80,736 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $2,295,000 | -27.2% | 80,736 | -1.1% | 0.01% | -25.0% |
| Q4 2013 | $3,153,000 | +14.5% | 81,636 | -0.6% | 0.01% | 0.0% |
| Q3 2013 | $2,753,000 | +8.7% | 82,136 | -0.2% | 0.01% | +14.3% |
| Q2 2013 | $2,533,000 | – | 82,336 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |